Advertisement

Topics

Boehringer’s success gives EU another Humira biosimilar

09:11 EST 14 Nov 2017 | BioPharma-Reporter

The European Commission (EC) has approved Boehringer Ingelheimâs Humira (adalimumab) biosimilar, Cyltezo.

Original Article: Boehringer’s success gives EU another Humira biosimilar

NEXT ARTICLE

More From BioPortfolio on "Boehringer’s success gives EU another Humira biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...